Company: APAD
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001213900-25-108829
Chunk: 89

Company: AParadise Acquisition Corp.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 2
Chunk 89
---
ated (i) the purchase by the Sponsor of 400,000 private placement units (the “Sponsor Private Placement
Units”) on a private placement basis that occurred simultaneously with the consummation of the IPO, and (ii) the purchase by CCM
of 200,000 private placement units (the “Underwriter Private Placement Units” and together with the Sponsor Placement Units,
the “Private Placement Units”) on a private placement basis that occurred simultaneously with the consummation of the IPO,
at a price of $10.00 per Private Placement Unit, generating total proceeds of $6,000,000. The Company granted the underwriters a 45-day
option to purchase up to 3,000,000 additional Units to cover over-allotments, if any, which expired unexercised on September 12, 2025.

Five institutional investors (none of
which are affiliated with any member of management, the Sponsor or any other investor) have purchased, indirectly, through the purchase
of non-voting interests in our sponsor, an aggregate of 130,000 Non-Voting Private Placement Units at a price of $10.00 per unit ($1,300,000
in the aggregate). In connection with the non-voting sponsor investor indirectly purchasing, through the Sponsor, the Non-Voting Private
Placement Units allocated to the non-voting sponsor investors in connection with the closing of the IPO, the Sponsor issued non-voting
shares at a nominal purchaser price to the non-voting sponsor investors at the closing of the IPO, reflecting interests in an aggregate
of 1,368,421 Founder Shares held by the Sponsor.

Following the closing of the IPO on
July 31, 2025, an amount of $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the
Private Placement Units was placed in a trust account (the “Trust Account”), with Continental Stock Transfer & Trust Company
acting as trustee. Cash of $1,848,460 was held outside of the Trust Account and is available for the payment of the promissory note, payment
of accrued expenses and for working capital purposes.

Transaction costs amounted to $12,645,418 consisting
of $4,000,000 of cash underwriting fee which was paid in cash at the closing date of the IPO, $8,000,000 of deferred underwriting fee,
and $645,418 of other offering